Cardiff Oncology (CRDF) FCF Margin Growth (5y) (2016 - 2025)
Cardiff Oncology (CRDF) FCF Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 189,823.00 |
| Sep 30, 2025 | -634,554.00 |
| Jun 30, 2025 | 384,597.00 |
| Mar 31, 2025 | -760,337.00 |
| Dec 31, 2024 | -331,598.00 |
| Sep 30, 2024 | -3,926.00 |
| Jun 30, 2024 | 366,620.00 |
| Mar 31, 2024 | 161,146.00 |
| Dec 31, 2023 | 4,947.00 |
| Sep 30, 2023 | -192,887.00 |
| Jun 30, 2023 | -381,319.00 |
| Mar 31, 2023 | -476,004.00 |
| Dec 31, 2022 | -500,808.00 |
| Sep 30, 2022 | 288,417.00 |
| Jun 30, 2022 | -318,440.00 |
| Mar 31, 2022 | -75,859.00 |
| Dec 31, 2021 | 771,933.00 |
| Sep 30, 2021 | 169,983.00 |
| Jun 30, 2021 | 174,862.00 |
| Mar 31, 2021 | -211,578.00 |